Drugs / ALIS
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04677569 | Apr 2021 → Nov 2025 | pulmonary non-tuberculous mycobacterial infection | Insmed Incorporated | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALIS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04677569 ↗ |
| Route | Inhaled | “Inhalation via nebulization over approximately 6 to 15 minutes” NCT04677569 ↗ |